BLGO Financials Monday, July 14, 2014 12:30:29 PM

BLGO Financials Monday, July 14, 2014 12:30:29 PM
BioLargo, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 168 66 156 157
Cost of Revenue 30 40 45 125
Gross Profit 138 26 111 31
Operating Expenses
Research and Development 742 384 99 101
Sales, General and Admin. 2,005 4,354 3,165 4,120
Non-Recurring Items - - - -
Other 11 5 8 10
Operating Income (2,620) (4,718) (3,161) (4,199)
Income From Continuing Operations
Add'l Income/Expense Items - - - 124
Earnings Before Interest and Tax (2,620) (4,718) (3,161) (4,075)
Interest Expense 282 616 793 1,668
Earnings Before Tax (2,901) (5,334) (3,954) (5,742)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,901) (5,334) (3,954) (5,742)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,901) (5,334) (3,954) (5,742)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,901) (5,334) (3,954) (5,742)